Association between AHR Expression and Immune Dysregulation in Pancreatic Ductal Adenocarcinoma: Insights from Comprehensive Immune Profiling of Peripheral Blood Mononuclear Cells.

MLA

Bartkeviciene, Arenida, et al. “Association between AHR Expression and Immune Dysregulation in Pancreatic Ductal Adenocarcinoma: Insights from Comprehensive Immune Profiling of Peripheral Blood Mononuclear Cells.” Cancers, vol. 15, no. 18, Sept. 2023, p. 4639. EBSCOhost, https://doi.org/10.3390/cancers15184639.

APA

Bartkeviciene, A., Jasukaitiene, A., Zievyte, I., Stukas, D., Ivanauskiene, S., Urboniene, D., Maimets, T., Jaudzems, K., Vitkauskiene, A., Matthews, J., Dambrauskas, Z., & Gulbinas, A. (2023). Association between AHR Expression and Immune Dysregulation in Pancreatic Ductal Adenocarcinoma: Insights from Comprehensive Immune Profiling of Peripheral Blood Mononuclear Cells. Cancers, 15(18), 4639. https://doi.org/10.3390/cancers15184639

Chicago

Bartkeviciene, Arenida, Aldona Jasukaitiene, Inga Zievyte, Darius Stukas, Sandra Ivanauskiene, Daiva Urboniene, Toivo Maimets, et al. 2023. “Association between AHR Expression and Immune Dysregulation in Pancreatic Ductal Adenocarcinoma: Insights from Comprehensive Immune Profiling of Peripheral Blood Mononuclear Cells.” Cancers 15 (18): 4639. doi:10.3390/cancers15184639.